Exact Mass: 660.3594928

Coproporphyrinogen III

C36H44N4O8 (660.3158984)

Coproporphyrinogen III is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrinogen III is a tetrapyrrole dead-end product resulting from the spontaneous oxidation of the methylene bridges of coproporphyrinogen arising from heme synthesis. It is secreted in feces and urine. Coproporphyrinogen III is biosynthesized from the tetrapyrrole hydroxymethylbilane, which is converted by the action of uroporphyrinogen III synthase to uroporphyrinogen III. Uroporphyrinogen III is subsequently converted into coproporphyrinogen III through a series of four decarboxylations. Increased levels of coproporphyrinogens can indicate congenital erythropoietic porphyria or sideroblastic anemia, which are inherited disorders. Porphyria is a pathological state characterized by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: (1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, (2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, and (3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors include disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss and diminished utilization of coproporphyrinogen in the hepatocytes. This may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine. Decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion. Therefore, the coproporphyrin ring isomer ratio (1:III) becomes a sensitive index for impaired liver function, intrahepatic cholestasis, and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms (PMID: 3327428). Under certain conditions, coproporphyrinogen III can act as a phototoxin, a neurotoxin, and a metabotoxin. A phototoxin leads to cell damage upon exposure to light. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, hereditary coproporphyria (HCP), congenital erythropoietic porphyria, and sideroblastic anemia. In particular, coproporphyrinogen III is accumulated and excreted excessively in the feces in acute intermittent porphyria, protoporphyria, and variegate porphyria. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503). Coproporphyrinogen III oxidase is deficient in hereditary coproporphyria. These persons usually have enhanced excretion even in a subclinical state of the disease.(PubMed ID 14605502 ) [HMDB]. Coproporphyrinogen III is found in many foods, some of which are cucumber, climbing bean, horseradish, and pepper (c. frutescens). COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Coproporphyrinogen I

C36H44N4O8 (660.3158984)

Coproporphyrinogen I is a porphyrin metabolite arising from heme synthesis. Porphyrins are pigments found in both animal and plant life. Coproporphyrinogen I is a tetrapyrrole dead-end product resulting from the spontaneous oxidation of the methylene bridges of coproporphyrinogen arising from heme synthesis. It is secreted in feces and urine. Coproporphyrinogen I is biosynthesized from the tetrapyrrole hydroxymethylbilane, which is converted by the action of uroporphyrinogen synthase to uroporphyrinogen I. Uroporphyrinogen I is subsequently converted into coproporphyrinogen I through a series of four decarboxylations. Increased levels of coproporphyrinogens can indicate congenital erythropoietic porphyria or sideroblastic anemia, which are inherited disorders. Porphyria is a pathological state characterized by abnormalities of porphyrin metabolism and results in the excretion of large quantities of porphyrins in the urine and in extreme sensitivity to light. A large number of factors are capable of increasing porphyrin excretion, owing to different and multiple causes and etiologies: (1) the main site of the chronic hepatic porphyria disease process concentrates on the liver, (2) a functional and morphologic liver injury is almost regularly associated with this chronic porphyria, and (3) the toxic form due to occupational and environmental exposure takes mainly a subclinical course. Hepatic factors include disturbance in coproporphyrinogen metabolism, which results from inhibition of coproporphyrinogen oxidase as well as from the rapid loss and diminished utilization of coproporphyrinogen in the hepatocytes. This may also explain why coproporphyrin, its autoxidation product, predominates physiologically in the urine. Decreased biliary excretion of coproporphyrin leading to a compensatory urinary excretion. Therefore, the coproporphyrin ring isomer ratio becomes a sensitive index for impaired liver function, intrahepatic cholestasis, and disturbed activity of hepatic uroporphyrinogen decarboxylase. In itself, secondary coproporphyrinuria is not associated with porphyria symptoms of a hepatologic-gastroenterologic, neurologic, or dermatologic order, even though coproporphyrinuria can occur with such symptoms (PMID: 3327428). Under certain conditions, coproporphyrinogen I can act as a phototoxin, a neurotoxin, and a metabotoxin. A phototoxin leads to cell damage upon exposure to light. A neurotoxin causes damage to nerve cells and nerve tissues. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, hereditary coproporphyria (HCP), congenital erythropoietic porphyria, and sideroblastic anemia. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503). Coproporphyrinogen I can be found in a number of food items, including cascade huckleberry, hyacinth bean, horseradish tree, and watercress. Formed by Uroporphyrinogen decarboxylase from Uroporphyrinogen I by decarboxylation of 4 acetates. [HMDB]. Coproporphyrinogen I is found in many foods, some of which are alpine sweetvetch, japanese persimmon, komatsuna, and celery leaves.

Capsianoside I

C32H52O14 (660.3356891999999)

Capsianosides are acyclic diterpene glycosides, water-soluble constituents present in the fruits of Paprika (Paprika Capsicum annuum L. var. grossum Bailey) and Jalapeno (Jalapeno Capsicum annuum L. var. annuum), that are used as vegetables and spices. Paprika is known for its high vitamin C content and has been isolated from Hungarian paprika in large amounts. Jalapeno is a stimulating spice which contains capsaicin and related compounds in its fruits and veins. (PMID: 17015971). The genus Capsicum (Solanaceae) includes many species widely cultivated in Asia, Africa, and Mediterranean countries. Peppers are native plants of America, and the fruits (pericarps) are consumed as vegetable foods, spices, and external medicines and are also a source of vitamins A, C, and E. Hot chili pepper has been used for centuries as a condiment to aid digestion. Traditionally, medical doctors advise ulcer patients not to consume spicy foods like pungent capsicum products, while naturopaths and herbalists have tended to use hot seasonings to relieve ulcers. Phytochemical investigations have been mainly focused on hot components of pepper species and qualitative and quantitative determinations of phenolic metabolites with antioxidant activities. (PMID: 17002415). Constituent of Capsicum annuum variety fascuilatum

26-Deoxyactein

C37H56O10 (660.3873276)

PA(10:0/PGE2)

C33H57O11P (660.3638301999999)

PA(10:0/PGE2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/PGE2), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE2/10:0)

C33H57O11P (660.3638301999999)

PA(PGE2/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE2/10:0), in particular, consists of one chain of one Prostaglandin E2 at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/PGD2)

C33H57O11P (660.3638301999999)

PA(10:0/PGD2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/PGD2), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD2/10:0)

C33H57O11P (660.3638301999999)

PA(PGD2/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD2/10:0), in particular, consists of one chain of one Prostaglandin D2 at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C33H57O11P (660.3638301999999)

PA(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0)

C33H57O11P (660.3638301999999)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0), in particular, consists of one chain of one Lipoxin A4 at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

26-Deoxyactein

C37H56O10 (660.3873276)

26-Deoxyactein is a triterpenoid. It has a role as a metabolite. 26-Deoxyactein is a natural product found in Actaea elata, Actaea cimicifuga, and Actaea racemosa with data available. See also: Black Cohosh (part of). A natural product found in Actaea racemosa.

Gypsogenin-3-O-glucuronide

C37H56O10 (660.3873276)

Gypsogenin-3-O-glucuronide is a ubiquitous saponin precursor in plants of the genus Gypsophila[1]. Gypsogenin-3-O-glucuronide is a ubiquitous saponin precursor in plants of the genus Gypsophila[1].

(-)-Umbellamine

C41H48N4O4 (660.3675367999999)

27-Deoxyactein

C37H56O10 (660.3873276)

Khekadaengoside C

C36H52O11 (660.3509442)

Accedinine

C41H48N4O4 (660.3675367999999)

Villalstonine

C41H48N4O4 (660.3675367999999)

Cimiracemoside K

C37H56O10 (660.3873276)

A natural product found in Actaea racemosa.

Wikstroelide J

C36H52O11 (660.3509442)

Gambogoic acid A

C39H48O9 (660.3298158)

Khekadaengoside I

C36H52O11 (660.3509442)

(-)-Reveromycin B

C36H52O11 (660.3509442)

Reveromycin A

C36H52O11 (660.3509442)

25-O-acetyl-7,8-didehydrocimigenol 3-O-alpha-L-arabinopyranoside

C37H56O10 (660.3873276)

C36H52O11

C36H52O11 (660.3509442)

CUMINDYSOSIDE A

C37H56O10 (660.3873276)

rosmanoyl carnosate

C40H52O8 (660.3661992000001)

C37H56O10

C37H56O10 (660.3873276)

Lepranthin

C32H52O14 (660.3356891999999)

19-hydroxyervafoline

C40H44N4O5 (660.3311534)

15-oxozoapatlin-13alpha-yl-10alpha,16alpha-dihydroxy-9alpha-methyl-20-nor-kauran-19-oic acid gamma-lactone-17-oate

C40H52O8 (660.3661992000001)

gambogenin dimethyl acetal

C40H52O8 (660.3661992000001)

(18S)-hydroxyneodihydroprotolichesterinic acid 18-O-alpha-L-rhamnopyranosyl-(1-2)-O-beta-D-glucopyranoside-(21,2-lactone)|gobienine B

C33H56O13 (660.3720726)

meliavolen

C41H56O7 (660.4025826)

16alpha,17-dihydroxy-ent-kauran-19-oic acid, 16-O-beta-D-glucopyranoside 19-O-beta-D-glucopyranosyl|acantrifoside D|beta-D-glucopyranosyl 17-hydroxy-ent-kauran-19-oate-16-O-beta-D-glucopyranoside

C32H52O14 (660.3356891999999)

C41H56O7

C41H56O7 (660.4025826)

3,11,22-Trioxo-16??-hydroxy-(20S,24)-epoxy-cucurbit-5,23-diene-2??-O-??-D-glucopyranoside

C36H52O11 (660.3509442)

xylorumphiin A

C35H48O12 (660.3145608)

2-{[5,7-dihydroxy-2-methyl-2-(4-methyl-3-pentenyl)-8-butanoyl-6-chromenyl]methyl}-3,5-dihydroxy-4-methyl-4-(3,7-dimethyl-2,6-octadienyl)-6-acetyl-2,5-cyclohexadien-1-one|yungensin C

C40H52O8 (660.3661992000001)

1alpha,11beta-diacetoxy-4alpha-carbomethoxy-7alpha-hydroxy-12alpha-(2-methylpropanoyloxy)-15-oxohavanensin

C35H48O12 (660.3145608)

wattoside D

C33H56O13 (660.3720726)

2-O-beta-D-glucopyranosyl cucurbitacin S

C36H52O11 (660.3509442)

(25S)-5beta-furostan-1beta,2beta,3beta,4beta,5beta,22alpha,26-heptaol-26-O-beta-D-glucoside

C33H56O13 (660.3720726)

aphanamene B

C40H52O8 (660.3661992000001)

cercosporene F

C40H52O8 (660.3661992000001)

11alpha,12alpha-epoxy-3beta-[(O-beta-D-glucuronopyranoside-6-O-methly ester)oxy]olean-28,13-olide|gardeniside A

C37H56O10 (660.3873276)

Aphadilactone B

C40H52O8 (660.3661992000001)

pipestelide C

C36H44N4O8 (660.3158984)

21,24,25-triacetyl-7-deacetyl-6-hydroxylbrujavanone E

C36H52O11 (660.3509442)

aphanalide G

C35H48O12 (660.3145608)

Callistenone E

C40H52O8 (660.3661992000001)

villalstonidine F

C41H48N4O4 (660.3675367999999)

C39H52N2O7

C39H52N2O7 (660.3774322000002)

C35H48O12

C35H48O12 (660.3145608)

4-apo-beta-caroten-4-oic acid beta-D-glucopyranoside|neurosporaxanthin beta-D-glucopyranoside

C41H56O7 (660.4025826)

suavioside G

C32H52O14 (660.3356891999999)

3beta-O-(4-deoxy-beta-D-hex-4-enopyranosyluronic acid), 2beta-hydroxy-olean-12-en-23,18-dioic acid

C36H52O11 (660.3509442)

01-185-17-8|PNG01-185-017-8|PNG01-185-17-8

C39H48O9 (660.3298158)

3-O-(3-Acetyl-beta-D-xylopyranoside)--16,23:16,24-Diepoxycycloart-7-ene-3,15,25-triol

C37H56O10 (660.3873276)

Trp Leu Lys Ser Asn

C31H48N8O8 (660.3594928)

Tyr Val Arg Pro Leu

C32H52N8O7 (660.3958762)

23-epi-26-Deoxyactein

C37H56O10 (660.3873276)

23-epi-26-deoxyactein is a triterpenoid. It has a role as a metabolite. 23-EPI-26-Deoxyactein is a natural product found in Actaea racemosa with data available. See also: Black Cohosh (part of). A natural product found in Actaea racemosa. 23-epi-26-Deoxyactein is a natural and orally active anti-obesity and anti-cancer compound[1][2][3].

25-O-acetyl-7,8-didehydro-cimigenol-3-O-b-Dxylopyaranoside

C37H56O10 (660.3873276)

C37H56O10_(2S,4aR,5aR,7R,7aR,8R,12aS,12bS,14aR)-1,1,5,7a,8,12a-Hexamethyl-2-(D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1,8a]naphtho[2,1:4,5]indeno[2,1-b]pyran-10,2-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate

C37H56O10 (660.3873276)

C32H52O14_(2E,6E,10E)-14-{[2-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}-4-hydroxy-2,6,10,14-tetramethyl-2,6,10,15-hexadecatetraenoic acid

C32H52O14 (660.3356891999999)

(2E,6E,10E)-14-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoic acid

C32H52O14 (660.3356891999999)

(2E,6E,10E)-14-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoic acid_major

C32H52O14 (660.3356891999999)

His Arg Trp Tyr

C32H40N10O6 (660.313214)

His Arg Tyr Trp

C32H40N10O6 (660.313214)

His Trp Arg Tyr

C32H40N10O6 (660.313214)

His Trp Tyr Arg

C32H40N10O6 (660.313214)

His Tyr Arg Trp

C32H40N10O6 (660.313214)

His Tyr Trp Arg

C32H40N10O6 (660.313214)

Asn Arg Trp Trp

C32H40N10O6 (660.313214)

Asn Trp Arg Trp

C32H40N10O6 (660.313214)

Asn Trp Trp Arg

C32H40N10O6 (660.313214)

Arg His Trp Tyr

C32H40N10O6 (660.313214)

Arg His Tyr Trp

C32H40N10O6 (660.313214)

Arg Asn Trp Trp

C32H40N10O6 (660.313214)

Arg Trp His Tyr

C32H40N10O6 (660.313214)

Arg Trp Asn Trp

C32H40N10O6 (660.313214)

Arg Trp Trp Asn

C32H40N10O6 (660.313214)

Arg Trp Tyr His

C32H40N10O6 (660.313214)

Arg Tyr His Trp

C32H40N10O6 (660.313214)

Arg Tyr Trp His

C32H40N10O6 (660.313214)

Trp His Arg Tyr

C32H40N10O6 (660.313214)

Trp His Tyr Arg

C32H40N10O6 (660.313214)

Trp Asn Arg Trp

C32H40N10O6 (660.313214)

Trp Asn Trp Arg

C32H40N10O6 (660.313214)

Trp Arg His Tyr

C32H40N10O6 (660.313214)

Trp Arg Asn Trp

C32H40N10O6 (660.313214)

Trp Arg Trp Asn

C32H40N10O6 (660.313214)

Trp Arg Tyr His

C32H40N10O6 (660.313214)

Trp Trp Asn Arg

C32H40N10O6 (660.313214)

Trp Trp Arg Asn

C32H40N10O6 (660.313214)

Trp Tyr His Arg

C32H40N10O6 (660.313214)

Trp Tyr Arg His

C32H40N10O6 (660.313214)

Tyr His Arg Trp

C32H40N10O6 (660.313214)

Tyr His Trp Arg

C32H40N10O6 (660.313214)

Tyr Arg His Trp

C32H40N10O6 (660.313214)

Tyr Arg Trp His

C32H40N10O6 (660.313214)

Tyr Trp His Arg

C32H40N10O6 (660.313214)

Tyr Trp Arg His

C32H40N10O6 (660.313214)

Neurosporaxanthin β-D-glucopyranoside

C41H56O7 (660.4025826)

Capsianside I

C32H52O14 (660.3356891999999)

OKDdiA-PA

C33H57O11P (660.3638301999999)

Neurosporaxanthin beta-D-glucopyranoside

C41H56O7 (660.4025826)

D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

PA(10:0/PGE2)

C33H57O11P (660.3638301999999)

PA(PGE2/10:0)

C33H57O11P (660.3638301999999)

PA(10:0/PGD2)

C33H57O11P (660.3638301999999)

PA(PGD2/10:0)

C33H57O11P (660.3638301999999)

PA(10:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C33H57O11P (660.3638301999999)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/10:0)

C33H57O11P (660.3638301999999)

Yungensin C

C40H52O8 (660.3661992000001)

A natural product found in Elaphoglossum yungense.

lumutinine C

C41H48N4O4 (660.3675367999999)

A natural product found in Alstonia macrophylla.

Allodesmosine

C30H56N6O10+6 (660.4057716)

2-{5-[2-tert-butyl-7-(diethylamino)-4H-chromen-4-ylidene]penta-1,3-dien-1-yl}-1-(5-carboxypentyl)-3,3-dimethyl-3H-indolium-5-sulfonate

C38H48N2O6S (660.3232908)

N-[(3S,9R,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide

C40H44N4O5 (660.3311534)

N-[(3R,9S,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3S,9S,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3R,9R,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3S,9R,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

methyl (1R,21R,23R,24S,27E,28S,29S)-27-ethylidene-8,21,40-trimethyl-20,22-dioxa-8,25,30,40-tetrazaundecacyclo[23.11.2.16,17.124,28.01,23.03,21.04,18.07,15.09,14.023,30.031,36]tetraconta-7(15),9,11,13,31,33,35-heptaene-29-carboxylate

C41H48N4O4 (660.3675367999999)

N-[[(3S,9R,10R)-16-(benzenesulfonamido)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-4-(dimethylamino)-N-methylbutanamide

C34H52N4O7S (660.3556522000001)

N-[(3R,9R,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3R,9S,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3R,9R,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3S,9R,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

1-(1,3-benzodioxol-5-yl)-3-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(phenylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]urea

C37H48N4O7 (660.3522817999999)

N-[(3R,9R,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3S,9S,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3S,9S,10R)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3S,9S,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

N-[(3R,9S,10S)-9-[[benzenesulfonyl(methyl)amino]methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-(dimethylamino)butanamide

C34H52N4O7S (660.3556522000001)

[(1R,3R,4R,6R,12S,13S,16R,18S,21R)-1,4,6,12,17,17-hexamethyl-18-[(3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O10 (660.3873276)

[(2S,4S,5R,6R,7R,10S,12S,13R,14R,15R)-12-acetyloxy-2,10-bis[(2S)-2-acetyloxypropyl]-6,14-dihydroxy-5,7,13,15-tetramethyl-8,16-dioxo-1,9-dioxacyclohexadec-4-yl] acetate

C32H52O14 (660.3356891999999)

Smgdg O-18:5_5:0

C32H52O12S (660.3179312)

Smgdg O-20:5_3:0

C32H52O12S (660.3179312)

PEtOH 32:8

C37H57O8P (660.3790852)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C34H61O10P (660.4002135999999)

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C34H61O10P (660.4002135999999)

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H61O10P (660.4002135999999)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C34H61O10P (660.4002135999999)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C34H61O10P (660.4002135999999)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H61O10P (660.4002135999999)

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H57O8P (660.3790852)

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H57O8P (660.3790852)

[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C37H56O10 (660.3873276)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C37H57O8P (660.3790852)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-dodec-5-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C34H61O10P (660.4002135999999)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

C37H57O8P (660.3790852)

[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C37H56O10 (660.3873276)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C34H61O10P (660.4002135999999)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H57O8P (660.3790852)

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C34H61O10P (660.4002135999999)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C34H61O10P (660.4002135999999)

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)

coproporphyrinogen III

C36H44N4O8 (660.3158984)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Coproporphyrinogen I

C36H44N4O8 (660.3158984)

Capsianoside I

C32H52O14 (660.3356891999999)

MGDG O-28:8;O

C37H56O10 (660.3873276)

SMGDG O-23:5

C32H52O12S (660.3179312)

SQDG 23:4

C32H52O12S (660.3179312)

DGMG 17:4

C32H52O14 (660.3356891999999)

SQMG 24:4

C33H56O11S (660.3543146000001)

DGGA 25:1;O

C34H60O12 (660.408456)

DGGA 27:7

C36H52O11 (660.3509442)

MGGA 28:7

C37H56O10 (660.3873276)

PA O-31:4;O3

C34H61O10P (660.4002135999999)

PA P-20:0/11:3;O3

C34H61O10P (660.4002135999999)

PA 18:0/13:3;O2

C34H61O10P (660.4002135999999)

PA 18:1/12:3;O3

C33H57O11P (660.3638301999999)

PA 18:2/12:2;O3

C33H57O11P (660.3638301999999)

PA 22:1/8:3;O3

C33H57O11P (660.3638301999999)

PA 22:2/8:2;O3

C33H57O11P (660.3638301999999)

PA 22:2/9:1;O2

C34H61O10P (660.4002135999999)

PA 31:3;O2

C34H61O10P (660.4002135999999)

PG O-26:6;O3

C32H53O12P (660.3274468)

PG O-27:5;O2

C33H57O11P (660.3638301999999)

PG O-28:4;O

C34H61O10P (660.4002135999999)

PG P-16:0/12:3;O

C34H61O10P (660.4002135999999)

PG P-18:0/9:4;O2

C33H57O11P (660.3638301999999)

PG P-18:1/8:4;O3

C32H53O12P (660.3274468)

PG P-20:0/8:3;O

C34H61O10P (660.4002135999999)

PG P-20:1/7:3;O2

C33H57O11P (660.3638301999999)

PG 14:1/13:3;O

C33H57O11P (660.3638301999999)

PG 18:2/8:3;O2

C32H53O12P (660.3274468)

PG 18:3/8:2;O2

C32H53O12P (660.3274468)

PG 18:3/9:1;O

C33H57O11P (660.3638301999999)

PG 18:4/8:1;O2

C32H53O12P (660.3274468)

PG 20:1/7:3;O

C33H57O11P (660.3638301999999)

PG 22:4/4:1;O2

C32H53O12P (660.3274468)

PG 26:5;O2

C32H53O12P (660.3274468)

PG 27:4;O

C33H57O11P (660.3638301999999)

PG 10:0_18:3

C34H61O10P (660.4002135999999)

PG 28:3

C34H61O10P (660.4002135999999)

PEth 32:8

C37H57O8P (660.3790852)

PM 32:9;O

C36H53O9P (660.3427018)

PM 33:8

C37H57O8P (660.3790852)

ST 26:1;O8;GlcA

C32H52O14 (660.3356891999999)

ST 27:0;O7;GlcA

C33H56O13 (660.3720726)

ST 29:6;O6;GlcA

C35H48O12 (660.3145608)

ST 27:1;O8;Hex

C33H56O13 (660.3720726)

ST 28:0;O7;Hex

C34H60O12 (660.408456)

ST 29:7;O7;Hex

C35H48O12 (660.3145608)

Boc-Glu-Lys-Lys-AMC

C32H48N6O9 (660.3482598)

Boc-Glu-Lys-Lys-AMC is a sensitive fluorogenic substrate for urokinase-activated plasmin[1].

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 14-(hydroxymethyl)-5,9-dimethyl-14-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C32H52O14 (660.3356891999999)

(2s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

C41H56O7 (660.4025826)

6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-14-[(2-methylpropanoyl)oxy]-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylpropanoate

C35H48O12 (660.3145608)

(2r)-1-[(2s,4s,5r,6s,7s,10s,12s,13r,14s,15s)-4,12-bis(acetyloxy)-10-[(2r)-2-(acetyloxy)propyl]-6,14-dihydroxy-5,7,13,15-tetramethyl-8,16-dioxo-1,9-dioxacyclohexadecan-2-yl]propan-2-yl acetate

C32H52O14 (660.3356891999999)

6,7,34,35-tetrahydroxy-33-(hydroxymethyl)-5,12,29-trimethyl-2,4,9,14,30,32-hexaoxatetracyclo[29.4.0.0³,⁸.0¹¹,¹⁵]pentatriacontane-10,13-dione

C33H56O13 (660.3720726)

(1s,2s,5s,8r,11r,12r)-2,12-dimethyl-6-methylidene-7,17-dioxo-16-oxapentacyclo[10.3.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-5-yl (1s,2s,5r,6r,8s,11r,12r)-6-hydroxy-2,12-dimethyl-17-oxo-16-oxapentacyclo[10.3.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-6-carboxylate

C40H52O8 (660.3661992000001)

methyl 5,9-dimethyl-14-methylidene-15-{[3,4,5-tris(acetyloxy)-6-[(prop-1-en-2-yloxy)methyl]oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C36H52O11 (660.3509442)

2-hydroxy-3,8,8,17,19-pentamethyl-22-(prop-1-en-2-yl)-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate

C37H56O10 (660.3873276)

(2e,4r,6e,10e,14s)-14-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoic acid

C32H52O14 (660.3356891999999)

(2e,6e,10e)-14-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoic acid

C32H52O14 (660.3356891999999)

(2s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

C41H56O7 (660.4025826)

cimiracemoside j

C37H56O10 (660.3873276)

16,23:16,24-diepoxycycloart-7-ene-3,15,25-triol; (3β,15α,23r,24r)-form,3-o-(3-acetyl-beta-d-xylopyranoside)

C37H56O10 (660.3873276)

{"Ingredient_id": "HBIN001756","Ingredient_name": "16,23:16,24-diepoxycycloart-7-ene-3,15,25-triol; (3\u03b2,15\u03b1,23r,24r)-form,3-o-(3-acetyl-beta-d-xylopyranoside)","Alias": "NA","Ingredient_formula": "C37H56O10","Ingredient_Smile": "NA","Ingredient_weight": "660.83","OB_score": "NA","CAS_id": "150972-76-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9285","PubChem_id": "NA","DrugBank_id": "NA"}

23-epi-26-deoxyactein

C37H56O10 (660.3873276)

{"Ingredient_id": "HBIN004083","Ingredient_name": "23-epi-26-deoxyactein","Alias": "NA","Ingredient_formula": "C37H56O10","Ingredient_Smile": "CC1CC2(C3C(O3)(CO2)C)OC4C1C5(C(CC67CC68CCC(C(C8CCC7C5(C4)C)(C)C)OC9C(C(C(CO9)O)O)O)OC(=O)C)C","Ingredient_weight": "660.8 g/mol","OB_score": "8.3194382","CAS_id": "NA","SymMap_id": "SMIT12810","TCMID_id": "NA","TCMSP_id": "MOL011990","TCM_ID_id": "NA","PubChem_id": "101182169","DrugBank_id": "NA"}

3,11,22-trioxo-16α-hydroxy-(20s,24)-epoxy-cucurbit-5,23-diene-2β-o-β-d-glucopyrano-side

C36H52O11 (660.3509442)

{"Ingredient_id": "HBIN006895","Ingredient_name": "3,11,22-trioxo-16\u03b1-hydroxy-(20s,24)-epoxy-cucurbit-5,23-diene-2\u03b2-o-\u03b2-d-glucopyrano-side","Alias": "NA","Ingredient_formula": "C36H52O11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21969","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-α-(2''-o-acetyl)-d-xylopyranosyl-3β-hy-droxyolean-12-ene-28,29-dioicacid

C37H56O10 (660.3873276)

{"Ingredient_id": "HBIN009052","Ingredient_name": "3-o-\u03b1-(2''-o-acetyl)-d-xylopyranosyl-3\u03b2-hy-droxyolean-12-ene-28,29-dioicacid","Alias": "3-o-alpha-(2''-o-acetyl)-d-xylopyranosyl-3beta-hydroxyolean-12-ene-28,29-dioic acid","Ingredient_formula": "C37H56O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "533;30356","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

acantrifoside d

C32H52O14 (660.3356891999999)

{"Ingredient_id": "HBIN014359","Ingredient_name": "acantrifoside d","Alias": "NA","Ingredient_formula": "C32H52O14","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "93","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

acteol; 26-deoxy,12-ac,3-o-beta-d-xylopyranoside

C37H56O10 (660.3873276)

{"Ingredient_id": "HBIN014628","Ingredient_name": "acteol; 26-deoxy,12-ac,3-o-beta-d-xylopyranoside","Alias": "NA","Ingredient_formula": "C37H56O10","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7172","PubChem_id": "NA","DrugBank_id": "NA"}

cimiracemoside n

C37H56O10 (660.3873276)

(1r,2r,3s,4r,7r,9s,12r,14r,16r,17r,18r,19r,21r,22s)-2-hydroxy-3,8,8,17,19-pentamethyl-22-(prop-1-en-2-yl)-9-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate

C37H56O10 (660.3873276)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1r,4s,5r,9s,10r,13s,14r)-14-hydroxy-5,9,14-trimethyl-13-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C32H52O14 (660.3356891999999)

10-[9-butyl-8-(4-carboxy-3-methylbuta-1,3-dien-1-yl)-9-[(3-carboxypropanoyl)oxy]-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C36H52O11 (660.3509442)

5-(2-{3,7-dihydroxy-1-isopropyl-8a,10a-dimethyl-2,6-dioxo-1h,4h,7h,8h,9h,10h-cyclohexa[f]azulen-5-yl}ethyl)-2,7-dihydroxy-1-isopropyl-8a,10a-dimethyl-7h,8h,9h,10h-cyclohexa[f]azulene-3,6-dione

C40H52O8 (660.3661992000001)

(1r,3r)-1-[(2s)-3,3-dimethyloxiran-2-yl]-3-[(1r,3r,6s,8r,12r,13r,15r,16r)-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-15-yl]butyl acetate

C37H56O10 (660.3873276)

(2z)-4-[(1s,2s,8r,15s,16s,17s,19r)-12-hydroxy-16-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoic acid

C39H48O9 (660.3298158)

methyl (1r,3s,4s,6s,17s,18s,21r,23r,24s,27e,28s,29r)-27-ethylidene-8,21,40-trimethyl-20,22-dioxa-8,25,30,40-tetraazaundecacyclo[23.11.2.1⁶,¹⁷.1²⁴,²⁸.0¹,²³.0³,²¹.0⁴,¹⁸.0⁷,¹⁵.0⁹,¹⁴.0²³,³⁰.0³¹,³⁶]tetraconta-7(15),9,11,13,31,33,35-heptaene-29-carboxylate

C41H48N4O4 (660.3675367999999)

(1r,3r)-1-[(2s)-3,3-dimethyloxiran-2-yl]-3-[(1r,3r,6s,8r,12r,13r,15r,16r)-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-15-yl]butyl acetate

C37H56O10 (660.3873276)

methyl (1s,2r,4s,6s,7r,8r,9r,10r,11s,12s,14r,15s,16r,18r)-8,18-bis(acetyloxy)-6-(furan-3-yl)-12,14-dihydroxy-1,7,11,15-tetramethyl-9-[(2-methylpropanoyl)oxy]-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecane-15-carboxylate

C35H48O12 (660.3145608)

(1r,7s,10s,18s,21s,24s)-7,24-dihydroxy-15,29-diisopropyl-9,9,22,22-tetramethyl-2,17,32,33-tetraoxanonacyclo[16.8.4.2⁵,¹².2¹⁹,²⁶.0¹,¹⁸.0³,¹⁶.0⁴,¹³.0⁵,¹⁰.0²¹,²⁶]tetratriaconta-3,13,15,29-tetraene-27,28-dione

C40H52O8 (660.3661992000001)

[(2r,3s,4s,5r,6r)-6-{[(1s,2r,3r,5r,7r,10s,11r,14r,15s)-7-(acetyloxy)-2,6,6,10-tetramethyl-15-[(2s)-3-methylidene-4-oxobutan-2-yl]pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C37H56O10 (660.3873276)

(1s,1'r,2s,3'r,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O10 (660.3873276)

(4r)-2-acetyl-6-{[(2r)-8-butanoyl-5,7-dihydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]methyl}-4-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one

C40H52O8 (660.3661992000001)

(1s,1'r,2s,3'r,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4',5,6',12',17',17'-hexamethyl-18'-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O10 (660.3873276)

(1s,1'r,2r,3'r,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O10 (660.3873276)

(1s,2s,13s,15r)-15-[(2z)-4,4-dimethoxy-3-methylbut-2-en-1-yl]-7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8-dihydroxy-17,17-dimethyl-5-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione

C40H52O8 (660.3661992000001)

1-(3,3-dimethyloxiran-2-yl)-3-{13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-15-yl}butyl acetate

C37H56O10 (660.3873276)

(1r,2r,3as,3br,9ar,9br,11ar)-2-hydroxy-1-[(2r)-2-hydroxy-6-methyl-3-oxohept-6-en-2-yl]-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O11 (660.3509442)

2-hydroxy-1-(2-hydroxy-6-methyl-3-oxohept-6-en-2-yl)-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O11 (660.3509442)

(7r,8ar,10ar)-5-{2-[(1r,7s,8ar,10ar)-3,7-dihydroxy-1-isopropyl-8a,10a-dimethyl-2,6-dioxo-1h,4h,7h,8h,9h,10h-cyclohexa[f]azulen-5-yl]ethyl}-2,7-dihydroxy-1-isopropyl-8a,10a-dimethyl-7h,8h,9h,10h-cyclohexa[f]azulene-3,6-dione

C40H52O8 (660.3661992000001)

(1s,2r,3s,4r,7r,9s,12r,14r,16r,17r,18r,19r,21r,22s)-2-hydroxy-3,8,8,17,19-pentamethyl-22-(prop-1-en-2-yl)-9-{[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate

C37H56O10 (660.3873276)

2-{2-hydroxy-3,8,8,17,19-pentamethyl-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-22-yl}propan-2-yl acetate

C37H56O10 (660.3873276)

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (1s,4s,5r,9s,10r,13r,14r)-14-(hydroxymethyl)-5,9-dimethyl-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C32H52O14 (660.3356891999999)

(1r,2r,3as,3bs,9ar,9br,11ar)-2-hydroxy-1-[(2r)-2-hydroxy-6-methyl-3-oxohept-6-en-2-yl]-3a,6,6,9b,11a-pentamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione

C36H52O11 (660.3509442)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 14-hydroxy-5,9,14-trimethyl-13-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C32H52O14 (660.3356891999999)

4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O10 (660.3873276)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

C41H56O7 (660.4025826)

(6-{[7-(acetyloxy)-2,6,6,10-tetramethyl-15-(3-methylidene-4-oxobutan-2-yl)pentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl acetate

C37H56O10 (660.3873276)

1-[4,12-bis(acetyloxy)-10-[2-(acetyloxy)propyl]-6,14-dihydroxy-5,7,13,15-tetramethyl-8,16-dioxo-1,9-dioxacyclohexadecan-2-yl]propan-2-yl acetate

C32H52O14 (660.3356891999999)

(1s,3br,4r,5as,7r,9s,9as,9br,11as)-4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[(3s)-6-(propan-2-ylidene)oxan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C41H56O7 (660.4025826)

(1s,2s,4r,5s,6s,10s,11r,12r,13r,14s,15r)-13-(acetyloxy)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-tetradeca-2,4-dienoate

C36H52O11 (660.3509442)

(1r,8s,9s,10s)-3,4-dihydroxy-5-isopropyl-11,11-dimethyl-15-oxo-16-oxatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2,4,6-trien-8-yl (4ar,10as)-5,6-dihydroxy-7-isopropyl-1,1-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylate

C40H52O8 (660.3661992000001)

(2r,3s,4r,7r,9s,12r,14r,16r,17r,18r,19r,21r,22s)-2-hydroxy-3,8,8,17,19-pentamethyl-22-(prop-1-en-2-yl)-9-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate

C37H56O10 (660.3873276)

reveromycin b

C36H52O11 (660.3509442)

methyl 9,10-bis(acetyloxy)-1-(furan-3-yl)-4,7-dihydroxy-3b,6,9a,11a-tetramethyl-11-[(2-methylpropanoyl)oxy]-3-oxo-dodecahydrocyclopenta[a]phenanthrene-6-carboxylate

C35H48O12 (660.3145608)

methyl (1r,12s,14s,15e,18s)-15-ethylidene-12-[(1r,12r,13s,14s,15e)-15-ethylidene-1-hydroxy-13-(hydroxymethyl)-3-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-7-yl]-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H48N4O4 (660.3675367999999)

methyl (1r,4s,5r,9s,10r,13r,15r)-5,9-dimethyl-14-methylidene-15-{[(2r,3r,4r,5r,6r)-3,4,5-tris(acetyloxy)-6-[(prop-1-en-2-yloxy)methyl]oxan-2-yl]oxy}tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C36H52O11 (660.3509442)

(1r,3s,5s,6r,7r,8r,11r,12r,15s,29s,31r,33r,34s,35s)-6,7,34,35-tetrahydroxy-33-(hydroxymethyl)-5,12,29-trimethyl-2,4,9,14,30,32-hexaoxatetracyclo[29.4.0.0³,⁸.0¹¹,¹⁵]pentatriacontane-10,13-dione

C33H56O13 (660.3720726)

methyl 8,18-bis(acetyloxy)-6-(furan-3-yl)-12,14-dihydroxy-1,7,11,15-tetramethyl-9-[(2-methylpropanoyl)oxy]-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecane-15-carboxylate

C35H48O12 (660.3145608)

(2e,4r,5r,6e,8e)-10-[(2s,3r,6r,8r,9s)-9-butyl-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-9-[(3-carboxypropanoyl)oxy]-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C36H52O11 (660.3509442)

methyl (1s,3ar,3br,4r,5ar,6s,7r,9s,9as,9bs,10r,11r,11as)-9,10-bis(acetyloxy)-1-(furan-3-yl)-4,7-dihydroxy-3b,6,9a,11a-tetramethyl-11-[(2-methylpropanoyl)oxy]-3-oxo-dodecahydrocyclopenta[a]phenanthrene-6-carboxylate

C35H48O12 (660.3145608)

(1s,2s,4r,6s,7s,8r,9s,10r,13s,14s)-7,8-dihydroxy-2,8,10,13,18,18-hexamethyl-6-(2-methylprop-1-en-1-yl)-16-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-15,19-diene-12,17-dione

C36H52O11 (660.3509442)

3,4-dihydroxy-5-isopropyl-11,11-dimethyl-15-oxo-16-oxatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2,4,6-trien-8-yl 5,6-dihydroxy-7-isopropyl-1,1-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylate

C40H52O8 (660.3661992000001)

14-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoic acid

C32H52O14 (660.3356891999999)

2-[(1s,2s,3r,7s,9s,12r,14r,17r,18r,19r,21r,22s)-2-hydroxy-3,8,8,17,19-pentamethyl-9-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-22-yl]propan-2-yl acetate

C37H56O10 (660.3873276)

(2r,3r,4s,5r)-2-[2-(6-chlorododecyl)-5-(6-chlorotridecyl)-3-hydroxyphenoxy]oxane-3,4,5-triol

C36H62Cl2O6 (660.3923212)

2-[(1s,2s,3r,7s,9s,12r,14r,17r,18r,19r,21r,22s)-2-hydroxy-3,8,8,17,19-pentamethyl-9-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracos-4-en-22-yl]propan-2-yl acetate

C37H56O10 (660.3873276)

4-[12-hydroxy-16-methoxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoic acid

C39H48O9 (660.3298158)

(1s,7s,10s,18r,21s,24s)-7,24-dihydroxy-15,29-diisopropyl-9,9,22,22-tetramethyl-2,17,32,33-tetraoxanonacyclo[16.8.4.2⁵,¹².2¹⁹,²⁶.0¹,¹⁸.0³,¹⁶.0⁴,¹³.0⁵,¹⁰.0²¹,²⁶]tetratriaconta-3,13,15,29-tetraene-27,28-dione

C40H52O8 (660.3661992000001)

4,9-bis(acetyloxy)-3b,6,6,9a,11a-pentamethyl-1-[6-(propan-2-ylidene)oxan-3-yl]-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl benzoate

C41H56O7 (660.4025826)

n-(1-acetyl-2-oxopyrrolidin-3-yl)-3-hydroxy-4-{[hydroxy(2-{3-hydroxy-2-[(1-hydroxy-2-methoxyethylidene)amino]-4-methylpentanoyl}-1,2-diazinan-3-yl)methylidene]amino}-2-methyl-5-phenylpentanimidic acid

C32H48N6O9 (660.3482598)

(1s,2r,6r,7r,10r,11s,12s,14s,15s,16r,18r)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-14-[(2-methylpropanoyl)oxy]-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylpropanoate

C35H48O12 (660.3145608)

2,12-dimethyl-6-methylidene-7,17-dioxo-16-oxapentacyclo[10.3.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-5-yl 6-hydroxy-2,12-dimethyl-17-oxo-16-oxapentacyclo[10.3.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-6-carboxylate

C40H52O8 (660.3661992000001)

(1r,1'r,2s,3'r,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O10 (660.3873276)

2-acetyl-6-{[8-butanoyl-5,7-dihydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]methyl}-4-(3,7-dimethylocta-2,6-dien-1-yl)-3,5-dihydroxy-4-methylcyclohexa-2,5-dien-1-one

C40H52O8 (660.3661992000001)

(2s,3s,4s)-n-[(3s)-1-acetyl-2-oxopyrrolidin-3-yl]-3-hydroxy-4-({hydroxy[(3s)-2-[(2r,3r)-3-hydroxy-2-[(1-hydroxy-2-methoxyethylidene)amino]-4-methylpentanoyl]-1,2-diazinan-3-yl]methylidene}amino)-2-methyl-5-phenylpentanimidic acid

C32H48N6O9 (660.3482598)

(2s,4r,5s,6s,10s,11r,12r,13r,14s,15r)-13-(acetyloxy)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-tetradeca-2,4-dienoate

C36H52O11 (660.3509442)

(2e,4s,5s,6e,8e)-10-[(2r,7r,8s)-2-butyl-2-[(1s,2e,4e)-5-carboxy-1-[(3-carboxypropanoyl)oxy]-4-methylpenta-2,4-dien-1-yl]-8-methyl-1,6-dioxaspiro[4.5]decan-7-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C36H52O11 (660.3509442)

(1s,2s,4r,6s,7r,8r,9r,10r,13r,14r)-7,8-dihydroxy-2,8,10,13,18,18-hexamethyl-6-(2-methylprop-1-en-1-yl)-16-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-15,19-diene-12,17-dione

C36H52O11 (660.3509442)

7,8-dihydroxy-2,8,10,13,18,18-hexamethyl-6-(2-methylprop-1-en-1-yl)-16-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-15,19-diene-12,17-dione

C36H52O11 (660.3509442)

15-(4,4-dimethoxy-3-methylbut-2-en-1-yl)-7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8-dihydroxy-17,17-dimethyl-5-(3-methylbut-2-en-1-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione

C40H52O8 (660.3661992000001)

(4as,6as,6br,8ar,9s,10s,12ar,12br,14bs)-9-formyl-2,2,6a,6b,9,12a-hexamethyl-10-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(methoxycarbonyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C37H56O10 (660.3873276)